Glycan Arrays: From Basic Biochemical Research to Bioanalytical and Biomedical Applications

Annual Review of Analytical Chemistry

Volumn 9, Issue , 2016, Pages 223-247

  Geissner, Andreas ^a,b   Seeberger, Peter H ^a,b  

^a MAX PLANCK INSTITUTE OF COLLOIDS AND INTERFACES   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Biomarkers; Cancer; Glycoconjugate vaccines; Infectious diseases; Lectins

Indexed keywords

BIOMARKERS; BIOMOLECULES; BIOPOLYMERS; CARBOHYDRATES; DISEASES; MEDICAL APPLICATIONS; PROTEINS; VACCINES;

BASIC AND APPLIED RESEARCH; BIOMEDICAL APPLICATIONS; CANCER; GLYCOCONJUGATE VACCINES; GLYCOSYLTRANSFERASES; HIGH-THROUGHPUT ANALYSIS; INFECTIOUS DISEASE; LECTINS;

POLYSACCHARIDES;

POLYSACCHARIDE;

MEDICAL RESEARCH; MICROARRAY ANALYSIS;

BIOMEDICAL RESEARCH; MICROARRAY ANALYSIS; POLYSACCHARIDES;

EID: 84975462735     PISSN: 19361327     EISSN: 19361335     Source Type: Book Series    
DOI: 10.1146/annurev-anchem-071015-041641     Document Type: Review

References (155)

1. Mariño K, Bones J, Kattla JJ, Rudd PM. 2010. A systematic approach to protein glycosylation analysis: A path through the maze. Nat. Chem. Biol. 6(10):713-23
2. Adibekian A, Stallforth P, Hecht M, Werz DB, Gagneux P, Seeberger PH. 2011. Comparative bioinformatics analysis of the mammalian and bacterial glycomes. Chem. Sci. 2(2):337-44
3. Kline KA, Fälker S, Dahlberg S, Normark S, Henriques-Normark B. 2009. Bacterial adhesins in hostmicrobe interactions. Cell Host Microbe 5(6):580-92
4. de Groot PWJ, Bader O, de Boer AD, Weig M, ChauhanN. 2013. Adhesins in human fungal pathogens: glue with plenty of stick. Eukaryot. Cell 12(4):470-81
5. SmithDF, Cummings RD. 2014. Investigating virus-glycan interactions using glycan microarrays. Curr. Opin. Virol. 7:79-87
6. Astronomo RD, Burton DR. 2010. Carbohydrate vaccines: developing solutions to sticky situations? Nat. Rev. Drug Discov. 9(4):308-24
7. Lepenies B, Seeberger PH. 2010. The promise of glycomics, glycan arrays and carbohydrate-based vaccines. Immunopharmacol. Immunotoxicol. 32(2):196-207
8. Krishnegowda G,Hajjar AM, Zhu J, Douglass EJ, Uematsu S, et al. 2005. Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity. J. Biol. Chem. 280(9):8606-16
9. Pang P, Chiu PCN, Lee C, Chang L, Panico M, et al. 2011. Human sperm binding is mediated by the sialyl-LewisX oligosaccharide on the zona pellucida. Science 333(6050):1761-64
10. Ratner DM, Adams EW, Su J, O'Keefe BR, Mrksich M, Seeberger PH. 2004. Probing proteincarbohydrate interactions with microarrays of synthetic oligosaccharides. ChemBioChem 5(3):379-83
11. Wang D, Liu S, Trummer BJ, Deng C, Wang A. 2002. Carbohydrate microarrays for the recognition of cross-reactive molecular markers of microbes and host cells. Nat. Biotechnol. 20(3):275-81
12. Fukui S, Feizi T, Galustian C, Lawson AM, Chai W. 2002. Oligosaccharide microarrays for highthroughput detection and specificity assignments of carbohydrate-protein interactions. Nat. Biotechnol. 20(10):1011-17
13. Stowell SR, Arthur CM,McBride R, Berger O, Razi N, et al. 2014. Microbial glycan microarrays define key features of host-microbial interactions. Nat. Chem. Biol. 10(6):470-76
14. Palma AS, Liu Y, Zhang H, Zhang Y, McCleary BV, et al. 2015. Unravelling glucan recognition systems by glycome microarrays using the designer approach and mass spectrometry. Mol. Cell. Proteomics 14(4):974-88
15. Song X, Heimburg-Molinaro J, Cummings RD, Smith DF. 2014. Chemistry of natural glycan microarrays. Curr. Opin. Chem. Biol. 18:70-77
16. Geissner A, Anish C, Seeberger PH. 2014. Glycan arrays as tools for infectious disease research. Curr. Opin. Chem. Biol. 18:38-45
17. Rillahan CD, Paulson JC. 2011. Glycan microarrays for decoding the glycome. Annu. Rev. Biochem. 80(1):797-823
18. Blixt O, Head S, Mondala T, Scanlan C, Huflejt ME, et al. 2004. Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. PNAS 101(49):17033-38
19. Seeberger PH, Werz DB. 2007. Synthesis and medical applications of oligosaccharides. Nature 446(7139):1046-51
20. Boltje TJ, Buskas T, Boons GJ. 2009. Opportunities and challenges in synthetic oligosaccharide and glycoconjugate research. Nat. Chem. 1(8):611-22
21. Palma AS, Feizi T, Childs RA, Chai W, Liu Y. 2014. The neoglycolipid (NGL)-based oligosaccharide microarray system poised to decipher the meta-glycome. Curr. Opin. Chem. Biol. 18:87-94
22. Wang L, Cummings RD, Smith DF, Huflejt M, Campbell CT, et al. 2014. Cross-platform comparison of glycan microarray formats. Glycobiology 24(6):507-17
23. Byrd-Leotis L, Liu R, Bradley KC, Lasanajak Y, Cummings SF, et al. 2014. Shotgun glycomics of pig lung identifies natural endogenous receptors for influenza viruses. PNAS 111(22):E2241-50
24. Song X, LasanajakY,Xia B, Heimburg-Molinaro J,Rhea JM, et al. 2010. Shotgun glycomics: A microarray strategy for functional glycomics. Nat. Methods 8(1):85-90
25. van Diepen A, Smit CH, van Egmond L, Kabatereine NB, Pinot de Moira A, et al. 2012. Differential anti-glycan antibody responses in Schistosoma mansoni-infected children and adults studied by shotgun glycan microarray. PLOS Negl. Trop. Dis. 6(11):e1922
26. Yu Y, Lasanajak Y, Song X, Hu L, Ramani S, et al. 2014. Human milk contains novel glycans that are potential decoy receptors for neonatal rotaviruses. Mol. Cell. Proteom. 13(11):2944-60
27. Adams EW, Ratner DM, Bokesch HR, McMahon JB, O'Keefe BR, Seeberger PH. 2004. Oligosaccharide and glycoprotein microarrays as tools in HIV glycobiology: glycan-dependent gp120/protein interactions. Chem. Biol. 11(6):875-81
28. Wang C, Huang Y, Ren C, Lin C, Hung J, et al. 2008. Glycan microarray of Globo H and related structures for quantitative analysis of breast cancer. PNAS 105(33):11661-66
29. Srinivasan K, Raman R, Jayaraman A, Viswanathan K, Sasisekharan R, Menéndez-Arias L. 2013. Quantitative characterization of glycan-receptor binding of H9N2 influenza A virus hemagglutinin. PLOS ONE 8(4):e59550
30. Bryan MC, Fazio F, Lee H, Huang C, Chang A, et al. 2004. Covalent display of oligosaccharide arrays in microtiter plates. J. Am. Chem. Soc. 126(28):8640-41
31. Culf AS, Cuperlovic-Culf M, Ouellette RJ. 2006. Carbohydrate microarrays: survey of fabrication techniques. OMICS 10(3):289-310
32. Khan ZM, Liu Y, Neu U, Gilbert M, Ehlers B, et al. 2014. Crystallographic and glycan microarray analysis of human polyomavirus 9 VP1 identifies N-glycolyl neuraminic acid as a receptor candidate. J. Virol. 88(11):6100-11
33. Klein F, Gaebler C,Mouquet H, Sather DN, Lehmann C, et al. 2012. Broad neutralization by a combination of antibodies recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope protein. J. Exp. Med. 209(8):1469-79
34. GaoC,Liu Y, ZhangH,Zhang Y, FukudaMN,et al. 2014. Carbohydrate sequence of the prostate cancer-associated antigen F77 assigned by a mucin O-glycome designer array. J. Biol. Chem. 289(23):16462-77
35. Hanashima S, Götze S, Liu Y, Ikeda A, Kojima-Aikawa K, et al. 2015. Defining the interaction of human soluble lectin ZG16p and mycobacterial phosphatidylinositol mannosides. ChemBioChem 16(10):1502-11
36. DyukovaVI, Shilova NV,Galanina OE, Rubina A, BovinNV. 2006. Design of carbohydrate multiarrays. Biochim. Biophys. Acta Gen. Subj. 1760(4):603-9
37. Liu Y, Childs RA, Palma AS, Campanero-Rhodes MA, Stoll MS, et al. 2012. Neoglycolipid-based oligosaccharide microarray system: preparation of NGLs and their noncovalent immobilization on nitrocellulose-coated glass slides for microarray analyses. Methods Mol. Biol. 808:117-36
38. GraingerDW, Greef CH,Gong P,Lochhead MJ. 2007. Current microarray surface chemistries. Methods Mol. Biol. 381:37-57
39. Pereira CL, Geissner A, Anish C, Seeberger PH. 2015. Chemical synthesis elucidates the immunological importance of a pyruvate modification in the capsular polysaccharide of Streptococcus pneumoniae serotype 4. Angew. Chem. Int. Ed. 54(34):10016-19
40. Lee H, Chen C, Tsai T, Li S, Lin K, et al. 2014. Immunogenicity study of Globo H analogues with modification at the reducing or nonreducing end of the tumor antigen. J. Am. Chem. Soc. 136(48):16844-53
41. Matthies S, Stallforth P, Seeberger PH. 2015. Total synthesis of legionaminic acid as basis for serological studies. J. Am. Chem. Soc. 137(8):2848-51
42. Schumann B, Pragani R, Anish C, Pereira CL, Seeberger PH. 2014. Synthesis of conjugation-ready zwitterionic oligosaccharides by chemoselective thioglycoside activation. Chem. Sci. 5(5):1992-2002
43. Götze S, Azzouz N, Tsai Y, Groß U, Reinhardt A, et al. 2014. Diagnosis of toxoplasmosis using a synthetic glycosylphosphatidylinositol glycan. Angew. Chem. Int. Ed. 53(50):13701-5
44. Götze S, ReinhardtA,Geissner A, Azzouz N, Tsai Y, et al. 2015. Investigation of the protective properties of glycosylphosphatidylinositol-based vaccine candidates in a Toxoplasma gondii mouse challenge model. Glycobiology 25(9):984-91
45. Lee M, Shin I. 2005. Facile preparation of carbohydrate microarrays by site-specific, covalent immobilization of unmodified carbohydrates on hydrazide-coated glass slides. Org. Lett. 7(19):4269-72
46. Reinhardt A, Yang Y, ClausH, Pereira CL,Cox AD, et al. 2015. Antigenic potential of a highly conserved Neisseria meningitidis lipopolysaccharide inner core structure defined by chemical synthesis. Chem. Biol. 22(1):38-49
47. Park S, Gildersleeve JC, Blixt O, Shin I. 2013. Carbohydrate microarrays. Chem. Soc. Rev. 42(10):4310-26
48. Tateno H, Mori A, Uchiyama N, Yabe R, Iwaki J, et al. 2008. Glycoconjugate microarray based on an evanescent-field fluorescence-assisted detection principle for investigation of glycan-binding proteins. Glycobiology 18(10):789-98
49. Grant OC, Smith HM, Firsova D, Fadda E, Woods RJ. 2013. Presentation, presentation, presentation! Molecular-level insight into linker effects on glycan array screening data. Glycobiology 24(1):17-25
50. Liang P, Wang S, Wong C. 2007. Quantitative analysis of carbohydrate-protein interactions using glycan microarrays: determination of surface and solution dissociation constants. J. Am. Chem. Soc. 129(36):11177-84
51. Oyelaran O, Li Q, Farnsworth D, Gildersleeve JC. 2009. Microarrays with varying carbohydrate density reveal distinct subpopulations of serum antibodies. J. Proteome Res. 8(7):3529-38
52. Gerland B, Goudot A, Pourceau G, Meyer A, Dugas V, et al. 2012. Synthesis of a library of fucosylated glycoclusters and determination of their binding toward Pseudomonas aeruginosa lectin B (PA-IIL) using a DNA-based carbohydrate microarray. Bioconjug. Chem. 23(8):1534-47
53. Goudot A, Pourceau G, Meyer A, Gehin T, Vidal S, et al. 2013. Quantitative analysis (Kd and IC50) of glycoconjugates interactions with a bacterial lectin on a carbohydrate microarray with DNA direct immobilization (DDI). Biosens. Bioelectron. 40(1):153-60
54. Scurr DJ, Horlacher T, Oberli MA,Werz DB, Kroeck L, et al. 2010. Surface characterization of carbohydrate microarrays. Langmuir 26(22):17143-55
55. Muthana SM, Xia L, Campbell CT, Zhang Y, Gildersleeve JC. 2015. Competition between serum IgG, IgM, and IgA anti-glycan antibodies. PLOS ONE 10(3):e0119298
56. Martin CE, Broecker F, Eller S, Oberli MA, Anish C, et al. 2013. Glycan arrays containing synthetic Clostridium difficile lipoteichoic acid oligomers as tools toward a carbohydrate vaccine. Chem. Commun. 49(64):7159
57. Palma AS, Feizi T, Zhang Y, Stoll MS, Lawson AM, et al. 2006. Ligands for the beta-glucan receptor, Dectin-1, assigned using "designer" microarrays of oligosaccharide probes (neoglycolipids) generated from glucan polysaccharides. J. Biol. Chem. 281(9):5771-79
58. Levan S, De S, Olson R. 2013. Vibrio cholerae cytolysin recognizes the heptasaccharide core of complex N-glycans with nanomolar affinity. J. Mol. Biol. 425(5):944-57
59. Sulák O, Cioci G, Lameignère E, Balloy V, Round A, et al. 2011. Burkholderia cenocepacia BC2L-C is a super lectin with dual specificity and proinflammatory activity. PLOS Pathog. 7(9):e1002238
60. Hsu T, Cheng S, Yang W, Chin S, Chen B, et al. 2009. Profiling carbohydrate-receptor interaction with recombinant innate immunity receptor-Fc fusion proteins. J. Biol. Chem. 284(50):34479-89
61. Hromatka BS, Ngeleza S, Adibi JJ, Niles RK, Tshefu AK, Fisher SJ. 2013. Histopathologies, immunolocalization, and a glycan binding screen provide insights into Plasmodium falciparum interactions with the human placenta. Biol. Reprod. 88(6):154
62. Zupancic ML, Frieman M, SmithD, Alvarez RA,CummingsRD, Cormack BP. 2008. Glycan microarray analysis of Candida glabrata adhesin ligand specificity. Mol. Microbiol. 68(3):547-59
63. Takahara K, Arita T, Tokieda S, Shibata N, Okawa Y, et al. 2012. Difference in fine specificity to polysaccharides of Candida albicans mannoprotein between mouse SIGNR1 and human DC-SIGN. Infect. Immun. 80(5):1699-706
64. Park S, LeeM, Shin I. 2009. Construction of carbohydrate microarrays by using one-step, direct immobilizations of diverse unmodified glycans on solid surfaces. Bioconjugate Chem. 20(1):155-62
65. Moller I, Sørensen I, Bernal AJ, Blaukopf C, Lee K, et al. 2007. High-throughput mapping of cell-wall polymers within and between plants using novel microarrays. Plant J. 50(6):1118-28
66. Moller IE, Pettolino FA, Hart C, Lampugnani ER, Willats WGT, Bacic A. 2012. Glycan profiling of plant cell wall polymers using microarrays. J. Vis. Exp. (70):e4238
67. Fei Y, Sun Y, Li Y, Yu H, Lau K, et al. 2015. Characterization of receptor binding profiles of influenza A viruses using an ellipsometry-based label-free glycan microarray assay platform. Biomolecules 5(3):1480-98
68. Frederiksen RF, Yoshimura Y, Storgaard BG, Paspaliari DK, Petersen BO, et al. 2015. A diverse range of bacterial and eukaryotic chitinases hydrolyzes the LacNAc (Galβ1-4GlcNAc) and LacdiNAc (GalNAcβ1-4GlcNAc) motifs found on vertebrate and insect cells. J. Biol. Chem. 290(9):5354-66
69. Vidal-Melgosa S, Pedersen HL, Schückel J, Arnal G, Dumon C, et al. 2015. A new versatile microarray-based method for high throughput screening of carbohydrate-active enzymes. J. Biol. Chem. 290(14):9020-36
70. Park S, Shin I. 2007. Carbohydrate microarrays for assaying galactosyltransferase activity. Org. Lett. 9(9):1675-78
71. Brzezicka K, Echeverria B, Serna S, van Diepen A, Hokke CH, Reichardt N. 2015. Synthesis and microarray-assisted binding studies of core xylose and fucose containing N-glycans. ACS Chem. Biol. 10(5):1290-302
72. Yan S, Serna S, Reichardt N, Paschinger K, Wilson IBH. 2013. Array-assisted characterization of a fucosyltransferase required for the biosynthesis of complex core modifications of nematode N-glycans. J. Biol. Chem. 288(29):21015-28
73. Blixt O, Allin K, Bohorov O, Liu X, Andersson-Sand H, et al. 2008. Glycan microarrays for screening sialyltransferase specificities. Glycoconj. J. 25(1):59-68
74. Sanchez-Ruiz A, Serna S, Ruiz N, Martin-Lomas M, Reichardt N. 2011. MALDI-TOF mass spectrometric analysis of enzyme activity and lectin trapping on an array of N-glycans. Angew. Chem. Int. Ed. 50(8):1801-4
75. BanL,PettitN,LiL, Stuparu AD, Cai L, et al. 2012. Discovery of glycosyltransferases using carbohydrate arrays and mass spectrometry. Nat. Chem. Biol. 8(9):769-73
76. Oyelaran O, Gildersleeve JC. 2009. Glycan arrays: recent advances and future challenges. Curr. Opin. Chem. Biol. 13(4):406-13
77. Huebner M, Wutz K, Szkola A, Niessner R, Seidel M. 2013. A glyco-chip for the detection of ricin by an automated chemiluminescence read-out system. Anal. Sci. 29(4):461-66
78. Szkola A, Linares EM, Worbs S,Dorner BG, Dietrich R, et al. 2014. Rapid and simultaneous detection of ricin, staphylococcal enterotoxin B and saxitoxin by chemiluminescence-based microarray immunoassay. Analyst 139(22):5885-92
79. Takeuchi O, Akira S. 2010. Pattern recognition receptors and inflammation. Cell 140(6):805-20
80. Yang R, Rabinovich GA, Liu F. 2008. Galectins: structure, function and therapeutic potential. Expert Rev. Mol. Med. 10:e17
81. Crouch E, Hartshorn K, Horlacher T, McDonald B, Smith K, et al. 2009. Recognition of mannosylated ligands and influenza A virus by human surfactant protein D: contributions of an extended site and residue 343. Biochemistry 48(15):3335-45
82. Fasting C, Schalley CA, WeberM, Seitz O, Hecht S, et al. 2012. Multivalency as a chemical organization and action principle. Angew. Chem. Int. Ed. 51(42):10472-98
83. Sancho D, Reis e Sousa C. 2012. Signaling by myeloid C-type lectin receptors in immunity and homeostasis. Annu. Rev. Immunol. 30(1):491-529
84. Thiel S. 2007. Complement activating soluble pattern recognition molecules with collagen-like regions, mannan-binding lectin, ficolins and associated proteins. Mol. Immunol. 44(16):3875-88
85. Stowell SR, Arthur CM, Dias-Baruffi M, Rodrigues LC, Gourdine J, et al. 2010. Innate immune lectins kill bacteria expressing blood group antigen. Nat. Med. 16(3):295-301
86. Krarup A, Mitchell DA, Sim RB. 2008. Recognition of acetylated oligosaccharides by human L-ficolin. Immunol. Lett. 118(2):152-56
87. Gout E, Garlatti V, Smith DF, Lacroix M, Dumestre-Pérard C, et al. 2010. Carbohydrate recognition properties of human ficolins: glycan array screening reveals the sialic acid binding specificity ofM-ficolin. J. Biol. Chem. 285(9):6612-22
88. Horlacher T, Oberli MA, Werz DB, Kröck L, Bufali S, et al. 2010. Determination of carbohydratebinding preferences of human galectins with carbohydrate microarrays. ChemBioChem 11(11):1563-73
89. Stowell SR, Arthur CM, Mehta P, Slanina KA, Blixt O, et al. 2008. Galectin-1,-2, and-3 exhibit differential recognition of sialylated glycans and blood group antigens. J. Biol. Chem. 283(15):10109-23
90. Knirel YA, Gabius H, Blixt O, Rapoport EM, Khasbiullina NR, et al. 2014. Human tandem-repeat-type galectins bind bacterial non-βGal polysaccharides. Glycoconj. J. 31(1):7-12
91. Varki A. 2011. Since there are PAMPs and DAMPs, there must be SAMPs? Glycan "self-associated molecular patterns" dampen innate immunity, but pathogens can mimic them. Glycobiology 21(9):1121-24
92. Maglinao M, Eriksson M, Schlegel MK, Zimmermann S, Johannssen T, et al. 2014. A platform to screen for C-type lectin receptor-binding carbohydrates and their potential for cell-specific targeting and immune modulation. J. Control. Release 175:36-42
93. Powlesland AS, Ward EM, Sadhu SK, Guo Y, Taylor ME, Drickamer K. 2006. Widely divergent biochemical properties of the complete set of mouse DC-SIGN-related proteins. J. Biol. Chem. 281(29):20440-49
94. Macauley MS, Crocker PR, Paulson JC. 2014. Siglec-mediated regulation of immune cell function in disease. Nat. Rev. Immunol. 14(10):653-66
95. Diggle SP, Stacey RE, Dodd C, CamaraM,Williams P,Winzer K. 2006. The galactophilic lectin, LecA, contributes to biofilm development in Pseudomonas aeruginosa. Environ. Microbiol. 8(6):1095-104
96. Blanchard B, Nurisso A, Hollville E, Tétaud C,Wiels J, et al. 2008. Structural basis of the preferential binding for Globo-series glycosphingolipids displayed by Pseudomonas aeruginosa lectin I. J. Mol. Biol. 383(4):837-53
97. Lameignere E, MalinovskáL, SlávikováM,Duchaud E, Mitchell EP, et al. 2008. Structural basis for mannose recognition by a lectin from opportunistic bacteria Burkholderia cenocepacia. Biochem. J. 411(2):307
98. Zecconi A, Scali F. 2013. Staphylococcus aureus virulence factors in evasion from innate immune defenses in human and animal diseases. Immunol. Lett. 150(1-2):12-22
99. Hermans SJ, BakerHM, Sequeira RP, Langley RJ, Baker EN, Fraser JD. 2012. Structural and functional properties of staphylococcal superantigen-like protein 4. Infect. Immun. 80(11):4004-13
100. Hu H, Armstrong PCJ, Khalil E, Chen Y, Straub A, et al. 2011. GPVI andGPIbαmediate staphylococcal superantigen-like protein 5 (SSL5) induced platelet activation and direct toward glycans as potential inhibitors. PLOS ONE 6(4):e19190
101. Chung MC, Wines BD, Baker H, Langley RJ, Baker EN, Fraser JD. 2007. The crystal structure of staphylococcal superantigen-like protein 11 in complex with sialyl Lewis X reveals the mechanism for cell binding and immune inhibition. Mol. Microbiol. 66(6):1342-55
102. de Haas CJC, Weeterings C, Vughs MM, de Groot PG, Van Strijp JA, Lisman T. 2009. Staphylococcal superantigen-like 5 activates platelets and supports platelet adhesion under flow conditions, which involves glycoprotein Ibαand αIIbβ3. J. Thromb. Haemost. 7(11):1867-74
103. Byres E, Paton AW, Paton JC, Löfling JC, Smith DF, et al. 2008. Incorporation of a non-human glycan mediates human susceptibility to a bacterial toxin. Nature 456(7222):648-52
104. van Breedam W, Pöhlmann S, Favoreel HW, deGroot RJ,NauwynckHJ. 2014. Bitter-sweet symphony: glycan-lectin interactions in virus biology. FEMS Microbiol. Rev. 38(4):598-632
105. Rogers GN, Paulson JC. 1983. Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of theH3hemagglutinin based on species of origin. Virology 127(2):361-73
106. Stevens J, Blixt O, Glaser L, Taubenberger JK, Palese P, et al. 2006. Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J. Mol. Biol. 355(5):1143-55
107. Belser JA, Blixt O, Chen L, Pappas C, Maines TR, et al. 2008. Contemporary North American influenza H7 viruses possess human receptor specificity: implications for virus transmissibility. PNAS 105(21):7558-63
108. Childs RA, Palma AS, Wharton S, Matrosovich T, Liu Y, et al. 2009. Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray. Nat. Biotechnol. 27(9):797-99
109. Liu Y, Childs RA, Matrosovich T, Wharton S, Palma AS, et al. 2010. Altered receptor specificity and cell tropism of D222G hemagglutinin mutants isolated from fatal cases of pandemic A(H1N1) 2009 influenza virus. J. Virol. 84(22):12069-74
110. Bradley KC, Jones CA, Tompkins SM, Tripp RA, Russell RJ, et al. 2011. Comparison of the receptor binding properties of contemporary swine isolates and early human pandemicH1N1 isolates (novel 2009 H1N1). Virology 413(2):169-82
111. Stevens J, Blixt O, Chen L, Donis RO, Paulson JC, Wilson IA. 2008. Recent avian H5N1 viruses exhibit increased propensity for acquiring human receptor specificity. J. Mol. Biol. 381(5):1382-94
112. Crusat M, Liu J, Palma AS, Childs RA, Liu Y, et al. 2013. Changes in the hemagglutinin of H5N1 viruses during human infection-influence on receptor binding. Virology 447(1-2):326-37
113. de Vries RP, Zhu X, McBride R, Rigter A, Hanson A, et al. 2014. Hemagglutinin receptor specificity and structural analyses of respiratory droplet transmissible H5N1 viruses. J. Virol. 88(1):768-73
114. Sauer A, Liang C, Stech J, Peeters B, Quéré P, et al. 2014. Characterization of the sialic acid binding activity of influenza A viruses using soluble variants of the H7 and H9 hemagglutinins. PLOS ONE 9(2):e89529
115. ZaraketH, Baranovich T, Kaplan BS, Carter R, SongM, et al. 2015. Mammalian adaptation of influenza A(H7N9) virus is limited by a narrow genetic bottleneck. Nat. Commun. 6:6553
116. ZhangH, de Vries RP, Tzarum N, Zhu X, YuW, et al. 2015. A human-infecting H10N8 influenza virus retains a strong preference for avian-type receptors. Cell Host Microbe 17(3):377-84
117. Walther T, Karamanska R, Chan RWY, Chan MCW, Jia N, et al. 2013. Glycomic analysis of human respiratory tract tissues and correlation with influenza virus infection. PLOS Pathog. 9(3):e1003223
118. Alymova IV, Portner A,MishinVP, McCullers JA, Freiden P,Taylor GL. 2012. Receptor-binding specificity of the human parainfluenza virus type 1 hemagglutinin-neuraminidase glycoprotein. Glycobiology 22(2):174-80
119. Amonsen M, SmithDF, Cummings RD, AirGM. 2007. Human parainfluenza viruses hPIV1 and hPIV3 bind oligosaccharides with α2-3-linked sialic acids that are distinct from those bound by H5 avian influenza virus hemagglutinin. J. Virol. 81(15):8341-45
120. Mietzsch M, Broecker F, Reinhardt A, Seeberger PH, Heilbronn R. 2014. Differential adeno-associated virus serotype-specific interaction patternswith synthetic heparins and other glycans. J. Virol. 88(5):2991-3003
121. Diderrich R, Kock M, Maestre-ReynaM,Keller P, SteuberH, et al. 2015. Structural hot spots determine functional diversity of the Candida glabrata epithelial adhesin family. J. Biol. Chem. 290(32):19597-613
122. Muthana SM, Gildersleeve JC. 2014. Glycan microarrays: powerful tools for biomarker discovery. Cancer Biomark. 14(1):29-41
123. Kearney JF, Patel P, Stefanov EK, King RG. 2015. Natural antibody repertoires: development and functional role in inhibiting allergic airway disease. Annu. Rev. Immunol. 33(1):475-504
124. Huflejt ME, Vuskovic M, Vasiliu D, Xu H, Obukhova P, et al. 2009. Anti-carbohydrate antibodies of normal sera: findings, surprises and challenges. Mol. Immunol. 46(15):3037-49
125. Anish C, Schumann B, Pereira CL, Seeberger PH. 2014. Chemical biology approaches to designing defined carbohydrate vaccines. Chem. Biol. 21(1):38-50
126. Berti F, Adamo R. 2013. Recent mechanistic insights on glycoconjugate vaccines and future perspectives. ACS Chem. Biol. 8(8):1653-63
127. Geissner A, Pereira CL, Leddermann M, Anish C, Seeberger PH. 2016. Deciphering antigenic determinants of Streptococcus pneumoniae serotype 4 capsular polysaccharide using synthetic oligosaccharides. ACS Chem. Biol. 11(2)335-44
128. Broecker F, Hanske J, Martin CE, Baek JY, Wahlbrink A, et al. 2016. Multivalent display of minimal Clostridium difficile glycan epitopes mimics antigenic properties of larger glycans. Nat. Commun. 7:11224
129. Cazet A, Julien S, BobowskiM, Burchell J,Delannoy P. 2010. Tumour-associated carbohydrate antigens in breast cancer. Breast Cancer Res. 12(3):204
130. Danishefsky SJ, Shue Y, Chang MN, Wong C. 2015. Development of Globo-H cancer vaccine. Acc. Chem. Res. 48(3):643-52
131. Huang YL, Hung JT, Cheung SK, Lee HY, Chu KC, et al. 2013. Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer. PNAS 110(7):2517-22
132. Wandall HH, Blixt O, Tarp MA, Pedersen JW, Bennett EP, et al. 2010. Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes. Cancer Res. 70(4):1306-13
133. Pedersen JW, Blixt O, Bennett EP, Tarp MA, Dar I, et al. 2011. Seromic profiling of colorectal cancer patients with novel glycopeptide microarray. Int. J. Cancer 128(8):1860-71
134. Pedersen JW, Gentry-Maharaj A, Nøstdal A, Fourkala E, Dawnay A, et al. 2014. Cancer-associated autoantibodies to MUC1 and MUC4-a blinded case-control study of colorectal cancer in UK collaborative trial of ovarian cancer screening. Int. J. Cancer 134(9):2180-88
135. Wang D, Bhat R, Sobel RA, HuangW,Wang L, et al. 2014. Uncovering cryptic glycan markers inmultiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE). Drug Dev. Res. 75(3):172-88
136. Borchers AT,Keen CL,Huntley AC,GershwinME. 2015. Lyme disease: A rigorous review of diagnostic criteria and treatment. J. Autoimmun. 57:82-115
137. van Diepen A, van der Plas AJ, Kozak RP, Royle L, Dunne DW, Hokke CH. 2015. Development of a Schistosoma mansoni shotgun O-glycan microarray and application to the discovery of new antigenic schistosome glycan motifs. Int. J. Parasitol. 45(7):465-75
138. Schofield L, Hewitt MC, Evans K, Siomos M, Seeberger PH. 2002. Synthetic GPI as a candidate antitoxic vaccine in a model of malaria. Nature 418(6899):785-89
139. Kamena F, Tamborrini M, Liu X, Kwon Y, Thompson F, et al. 2008. Synthetic GPI array to study antitoxic malaria response. Nat. Chem. Biol. 4(4):238-40
140. Wang C, Li S, Lin T, Cheng Y, Sun T, et al. 2013. Synthesis of Neisseria meningitidis serogroup W135 capsular oligosaccharides for immunogenicity comparison and vaccine development. Angew. Chem. Int. Ed. 52(35):9157-61
141. Oberli MA, Hecht M, Bindschädler P, Adibekian A, Adam T, Seeberger PH. 2011. A possible oligosaccharide-conjugate vaccine candidate for Clostridium difficile is antigenic and immunogenic. Chem. Biol. 18(5):580-88
142. Martin CE, Broecker F, Oberli MA, Komor J, Mattner J, et al. 2013. Immunological evaluation of a synthetic Clostridium difficile oligosaccharide conjugate vaccine candidate and identification of a minimal epitope. J. Am. Chem. Soc. 135(26):9713-22
143. Gorry PR, Francella N, Lewin SR, Collman RG. 2014. HIV-1 envelope-receptor interactions required for macrophage infection and implications for current HIV-1 cure strategies. J. Leukoc. Biol. 95(1):71-81
144. Walker LM, Huber M, Doores KJ, Falkowska E, Pejchal R, et al. 2011. Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature 477(7365):466-70
145. Mouquet H, Scharf L, Euler Z, Liu Y, Eden C, et al. 2012. Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies. PNAS 109(47):E3268
146. Julien J, Sok D, Khayat R, Lee JH, Doores KJ, et al. 2013. Broadly neutralizing antibody PGT121 allosterically modulates CD4 binding via recognition of the HIV-1 gp120 V3 base and multiple surrounding glycans. PLOS Pathog. 9(5):e1003342
147. Moore JP, Fangel JU, Willats WGT, Vivier MA. 2014. Pectic-β(1,4)-galactan, extensin and arabinogalactan-protein epitopes differentiate ripening stages in wine and table grape cell walls. Ann. Bot. 114(6):1279-94
148. Zietsman AJJ, Moore JP, Fangel JU, WillatsWGT, Trygg J, VivierMA. 2015. Following the compositional changes of fresh grape skin cell walls during the fermentation process in the presence and absence of maceration enzymes. J. Agric. Food Chem. 63(10):2798-810
149. Runavot J, Guo X, Willats WGT, Knox JP, Goubet F, Meulewaeter F. 2014. Non-cellulosic polysaccharides from cotton fibre are differently impacted by textile processing. PLOS ONE 9(12):e115150
150. Schmidt D, Schuhmacher F, Geissner A, Seeberger PH, Pfrengle F. 2015. Automated synthesis of arabinoxylan-oligosaccharides enables characterization of antibodies that recognize plant cell wall glycans. Chem. Eur. J. 21(15):5709-13
151. Wang D, Carroll GT, Turro NJ, Koberstein JT, Kovác P, et al. 2007. Photogenerated glycan arrays identify immunogenic sugar moieties of Bacillus anthracis exosporium. Proteomics 7(2):180-84
152. Tateno H, Ohnishi K, Yabe R,Hayatsu N, Sato T, et al. 2010. Dual specificity of langerin to sulfated and mannosylated glycans via a single C-type carbohydrate recognition domain. J. Biol. Chem. 285(9):6390-400
153. Tateno H, Yabe R, Sato T, Shibazaki A, Shikanai T, et al. 2012. Human ZG16p recognizes pathogenic fungi through non-self polyvalent mannose in the digestive system. Glycobiology 22(2):210-20
154. Otto DM, Campanero-Rhodes MA, Karamanska R, Powell AK, Bovin N, et al. 2011. An expression system for screening of proteins for glycan and protein interactions. Anal. Biochem. 411(2):261-70
155. Campbell CT, Gulley JL, Oyelaran O, Hodge JW, Schlom J, Gildersleeve JC. 2014. Humoral response to a viral glycan correlates with survival on PROSTVAC-VF. PNAS 111(17):E1749-58